2019 Annual Meeting | C120 - Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography

Date Monday 05/06/19

Time 03:30 PM - 05:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Ruple S. Laughlin, MD, F�鶹��ýӳ��

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should be able to demonstrate a how to approach a neuromuscular patient electrodiagnostically and utilize nerve conduction studies and needle examination to evaluate suspected peripheral neuropathy, myopathy, mononeuropathies and radiculopathies. The program will emphasize case-based application of knowledge acquired in Clinical EMG I.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM EDT	Speaker	Introduction Ruple S. Laughlin, MD, F�鶹��ýӳ��
03:35 PM - 04:10 PM EDT	Speaker	Case-based EMG Applications: Peripheral Neuropathy Ruple S. Laughlin, MD, F�鶹��ýӳ��
04:10 PM - 04:45 PM EDT	Speaker	Case-based EMG Applications: Myopathy and Weakness Charles Kassardjian, MD, F�鶹��ýӳ��
04:45 PM - 05:20 PM EDT	Speaker	Case-based EMG Applications: Mononeuropathies, Plexopathies, and Radiculopathies John C. Kincaid, MD, F�鶹��ýӳ��
05:20 PM - 05:30 PM EDT	Q&A	Questions and Answers Ruple S. Laughlin, MD, F�鶹��ýӳ��, John C. Kincaid, MD, F�鶹��ýӳ��, Charles Kassardjian, MD, F�鶹��ýӳ��
05:30 PM - 06:00 PM EDT	Discussion	Continuing the Conversation

Faculty Disclosures
Ruple S. Laughlin, MD, F�鶹��ýӳ��	Dr. Laughlin has nothing to disclose.
John C. Kincaid, MD, F�鶹��ýӳ��	Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for strongbridge pharmaceuticals. Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for social security administrstion. The institution of Dr. Kincaid has received research support from Ionis Pharmaceuticals. Dr. Kincaid has received publishing royalties from a publication relating to health care. Dr. Kincaid has received personal compensation in the range of $500-$4,999 for serving as a medical expert for disability cases with social security administrstion. Dr. Kincaid has a non-compensated relationship as a I am the historian of the Board of Directors for this organization with �鶹��ýӳ��EM that is relevant to �鶹��ýӳ�� interests or activities.
Charles Kassardjian, MD, F�鶹��ýӳ��	Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Kassardjian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.